Vir Biotechnology, Inc. (VIR)
11.30
-0.45
(-3.83%)
USD |
NASDAQ |
Oct 30, 16:00
11.46
+0.16
(+1.42%)
After-Hours: 20:00
Vir Biotechnology Price : 11.30 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 11.63 | 11.84 | 11.18 | 11.30 | 1.270M |
| Oct 29, 2026 | 11.69 | 12.19 | 11.55 | 11.75 | 1.422M |
| Oct 28, 2026 | 11.11 | 11.94 | 11.11 | 11.93 | 1.558M |
| Oct 27, 2026 | 11.00 | 11.63 | 10.86 | 11.57 | 1.974M |
| Oct 26, 2026 | 10.64 | 11.10 | 10.60 | 11.04 | 1.587M |
| Oct 23, 2026 | 10.36 | 10.59 | 10.03 | 10.57 | 1.694M |
| Oct 22, 2026 | 10.51 | 10.75 | 10.18 | 10.43 | 987074.0 |
| Oct 21, 2026 | 10.80 | 11.02 | 10.55 | 10.57 | 1.137M |
| Oct 20, 2026 | 10.19 | 10.88 | 10.14 | 10.74 | 1.343M |
| Oct 19, 2026 | 10.04 | 10.30 | 9.96 | 10.21 | 1.309M |
| Oct 16, 2026 | 10.49 | 10.49 | 9.91 | 9.96 | 1.736M |
| Oct 15, 2026 | 10.38 | 10.67 | 10.20 | 10.47 | 1.418M |
| Oct 14, 2026 | 10.95 | 11.11 | 10.34 | 10.41 | 2.768M |
| Oct 13, 2026 | 11.21 | 11.25 | 10.60 | 10.61 | 1.784M |
| Oct 12, 2026 | 11.63 | 11.82 | 11.21 | 11.30 | 1.086M |
| Oct 09, 2026 | 11.11 | 12.00 | 10.97 | 11.70 | 1.965M |
| Oct 08, 2026 | 11.52 | 11.56 | 10.73 | 11.12 | 3.071M |
| Oct 07, 2026 | 11.32 | 11.76 | 11.32 | 11.52 | 3.562M |
| Oct 06, 2026 | 11.90 | 11.90 | 11.25 | 11.60 | 2.587M |
| Oct 05, 2026 | 11.17 | 11.87 | 10.92 | 11.78 | 3.147M |
| Oct 02, 2026 | 11.55 | 11.73 | 10.95 | 11.17 | 2.181M |
| Oct 01, 2026 | 10.86 | 11.61 | 10.86 | 11.29 | 2.576M |
| Sep 30, 2026 | 10.70 | 11.26 | 10.54 | 11.18 | 1.738M |
| Sep 29, 2026 | 10.49 | 10.84 | 10.34 | 10.65 | 1.574M |
| Sep 28, 2026 | 10.56 | 10.69 | 10.33 | 10.51 | 1.370M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 221.72 |
| Vaxcyte, Inc. | 62.03 |
| Caribou Biosciences, Inc. | 0.4232 |
| Arrowhead Pharmaceuticals, Inc. | 59.90 |
| Oncolytics Biotech, Inc. | 0.4254 |
Price Related Metrics
| PS Ratio | 5.538 |
| Price to Book Value | 1.946 |
| Earnings Yield | -16.47% |
| Market Cap | 1.912B |